Elston George

EyePoint Pharmaceuticals, Inc. · Chief Financial Officer

Elston George is listed in public filings as officer: Chief Financial Officer. This Elston George insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include EyePoint Pharmaceuticals, Inc. (EYPT). Investors use Elston George's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
EyePoint Pharmaceuticals, Inc.EYPT	--7.5k shares	Grant / ExerciseMay 25, 2026	Disclosure amount unavailable7.5k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$1.2M91.7k shares	Grant / ExerciseMay 25, 2026	$46.9K3.6k shares	$12.93	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
EyePoint Pharmaceuticals, Inc.EYPT	--30k shares	Grant / ExerciseMar 2, 2026	Disclosure amount unavailable5k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	--15.3k shares	Grant / ExerciseJan 6, 2026	Disclosure amount unavailable15.3k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$1.5M91.9k shares	Grant / ExerciseJan 6, 2026	$75.7K4.5k shares	$16.86	--
EyePoint Pharmaceuticals, Inc.EYPT	--15k shares	Grant / ExerciseJan 5, 2026	Disclosure amount unavailable15k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$1.4M81.1k shares	Grant / ExerciseJan 5, 2026	$76.7K4.4k shares	$17.43	--
EyePoint Pharmaceuticals, Inc.EYPT	--39.3k shares	Grant / ExerciseJan 3, 2026	Disclosure amount unavailable19.7k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$1.2M70.5k shares	Grant / ExerciseJan 3, 2026	$110.5K6.3k shares	$17.48	--
EyePoint Pharmaceuticals, Inc.EYPT	$2.2M126k shares	Grant / ExerciseJan 2, 2026	$2.2M126k shares	$17.48	--
EyePoint Pharmaceuticals, Inc.EYPT	--63k shares	Grant / ExerciseJan 2, 2026	Disclosure amount unavailable63k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	--25k shares	Grant / ExerciseDec 19, 2025	Disclosure amount unavailable5k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	--20k shares	Grant / ExerciseSep 19, 2025	Disclosure amount unavailable20k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	--7.5k shares	Grant / ExerciseMay 25, 2025	Disclosure amount unavailable7.5k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$459k80.8k shares	Grant / ExerciseMay 25, 2025	$12.5K2.2k shares	$5.68	--
EyePoint Pharmaceuticals, Inc.EYPT	--5.8k shares	Grant / ExerciseFeb 9, 2025	Disclosure amount unavailable5.8k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	--14.7k shares	Grant / ExerciseJan 6, 2025	Disclosure amount unavailable15.3k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$595k68.6k shares	Grant / ExerciseJan 6, 2025	$41.7K4.8k shares	$8.68	--
EyePoint Pharmaceuticals, Inc.EYPT	--30k shares	Grant / ExerciseJan 5, 2025	Disclosure amount unavailable15k shares	--	--
EyePoint Pharmaceuticals, Inc.EYPT	$480k58.1k shares	Grant / ExerciseJan 5, 2025	$43.5K5.3k shares	$8.26	--
EyePoint Pharmaceuticals, Inc.EYPT	$966k117k shares	Grant / ExerciseJan 3, 2025	$966.4K117k shares	$8.26	--
EyePoint Pharmaceuticals, Inc.EYPT	--74k shares	Grant / ExerciseJan 3, 2025	Disclosure amount unavailable59k shares	--	--